Read + Share
Blum JL, Laird AD, Litton JK, Rugo HS, et al. Determinants of Response to Talazoparib in Patients with HER2-negative, Germline
BRCA1/2-mutated Breast Cancer. Clin Cancer Res 2022 Jan 28. pii: 1078-0432.CCR-21-2080.
PMID: 35091441
|
 |
|
Blum JL, Laird AD, Litton JK, Rugo HS, et al. Determinants of Response to Talazoparib in Patients with HER2-negative, Germline
BRCA1/2-mutated Breast Cancer. Clin Cancer Res 2022 Jan 28. pii: 1078-0432.CCR-21-2080.
PMID: 35091441
|
|
|
|